Brain : Positron Emission Tomography Tracers Beyond [18F]Fluorodeoxyglucose - 28/06/14

Résumé |
Several positron emission tomography (PET) radiopharmaceuticals beyond fluorodeoxyglucose (FDG) have been used to study the physiology and pathophysiology in neurosciences. This article provides a broad overview of some of the commonly studied radiopharmaceuticals for PET imaging in selected neurologic conditions, particularly attempting to study their clinical relevance. Future studies on the use of advanced PET imaging in delineating neural pathophysiology, drug development, and altering patient management and outcomes across the disciplines of neurosciences are needed.
Le texte complet de cet article est disponible en PDF.Keywords : Positron emission tomography, Brain, Central nervous system, Positron, Dementia, Parkinson disease, Epilepsy, Neuroinflammation
Plan
| Author Disclosures: None. |
Vol 9 - N° 3
P. 267-276 - juillet 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
